IGC Pharma, Inc.IGCNYSE
Loading
Net Income ScalingExpanding
Percentile Rank50
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-7.12M
Near historical average
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-7.33M
Historical baseline
PeriodValueYoY Change
2025$-7.12M+45.2%
2024$-13.00M-13.0%
2023$-11.51M+23.4%
2022$-15.02M-70.4%
2021$-8.81M-20.5%
2020$-7.32M-78.5%
2019$-4.10M-129.4%
2018$-1.79M+4.3%
2017$-1.87M+33.5%
2016$-2.81M-